Effects of paroxetine and sertraline on different tissues from the guinea-pig and rat

Medical Science Research

Volumn 25, Issue 2, 1997, Pages 93-96

  Velasco, A ^a,b   Maroto, M ^a   Saez, G C ^a   Duenas, A ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Alfa1 receptors; H1 receptors; Muscarinic receptors; Muscular tryptaminergic receptor; Paroxetine; Potassium; Sertraline

Indexed keywords

ACETYLCHOLINE; COCAINE; ESTRADIOL; HISTAMINE; NORADRENALIN; PAROXETINE; POTASSIUM ION; PROPRANOLOL; SERTRALINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFECT; FEMALE; GUINEA PIG; ILEUM CONTRACTION; MALE; NONHUMAN; RAT; SMOOTH MUSCLE CONTRACTION; UTERUS CONTRACTION; VAS DEFERENS;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030949806     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rudorfer, M. V. and Potter, W.Z. 1989. Drugs, 37, 713-738
2. Dechant, K.L. and Clissold, S.F. 1991. Drugs, 41, 225-252
3. Raptopoulus, R, McClelland, G.E. and Jackson, D. 1989. Acta Psychiatr. Scand., 80, 46-48
4. Thomas, D.R., Nelson, D.R. and Johnson, A.M. 1987. Psychopharmacology, 93, 193-200
5. Chovinard, G., Goodman, W. and Greist, J. 1990. Psychopharmacology Bulletin, 26, 279-284
6. Doogan, O.P. and Gaillard, V. 1988. J. Clin,. Psychiatry, 49, 46-51
7. Heym, J. and Koe, B.K. 1988. J. Clin. Psychiatry, 49, 40-45
8. Staff of the Department of Pharmacology University of Edinburgh 1970. Pharmacology Experiments on Isolated Preparations, pp. 58-63. Churchill Livingstone, Edinburgh
9. Alvarez, F.J., Velasco, A. and Palomares, J.L. 1988. Pharmacology, 37,225-231
10. Daly, M., Humphray, J.M. and Stables, R. 1981. Br. J. Pharmacol, 72, 49-54
11. de Jalon, P.D., Bayo, J.M. and de Jalon, M.G. 1945. Farmacoter. act., 3,313-318
12. Kitchen, I. 1984. Textbook of "in vitro"Practical Pharmacology, pp. 86-100. B lack well Scientific, Oxford
13. Orallo, F., Fontenla, J.A. and Cadavid, J. 1987. Rev. Farmacol. din. Exp., 4, 49-55
14. Arunlakshana, O. and Schild, H.O. 1959. Er. J. Pharmacol, 14, 48-58
15. Hassan, S.M., Waiscott, G. and Turner, P. 1985. Br. J. Clin. Pharmacol., 19,705-706
16. Kush, H. and Rudolf, G.A.E. 1990. Psychopharmacology, 102, 379-382
17. Velasco, A., Hervâs, J., Carvajal, A. and Alamo, C. 1997. Gen Pharmacol., in press
18. Gobbi, M., Cervo, L., Taddei, C. and Mennini. T. 1990. Neurochem. Int., 16,247-251
19. Gouret, C.J., Forsolt, R. and Wettstein, J.G. 1990. Arzneim. Forsh., 40, 633-640
20. de Souza, E.B. and Kuyatt, B.L. 1987. Synapse, 1, 488-496
21. Fuller, R.W. and Wong, D.T. 1987. J. Clin. PsychopharmacoL, 7, 36-43
22. Bolden-Watson, C. and Richelson, E. 1993. Life Sciences, 52, 1023-1029
23. Koe, B.K. 1990. J. Clin. Psychiatry, 51, 13-17
24. Aguglia, E., Casacchia, M. and Cassano, G.B. 1993. Int. Clin. PsychopharmacoL, 8, 197-202
25. Hytel, J. 1993. Nord, J. Psychiatry, 4, 5-12
26. Kerr, J.S., Sherwood, N. and Hindmarch, I. 1991. Psychopharmacology, 6, 313-317
27. Leonard, B.E. 1988. J. Clin. Psychiatry, 49, 12-17
28. Murdoch. D. and McTavis. D. 1992. Drues. 44. 604-624